Fresh Recalls

FDAClass II · Drug · Recall D-0662-2026 · Recalled July 15, 2026

Methohexital Sodium for Injection recall — ONESOURCE SPECIALTY PHARMA LIMITED

Agency report date: July 15, 2026.

1. Compare your item

This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.

Product named
Methohexital Sodium for Injection
Company / brand
ONESOURCE SPECIALTY PHARMA
Lot / serial / date codes
Lot #: 7000612A, Exp. Date 1/2028
Distribution
Nationwide within the United States
Agency product description and boundaries

Methohexital Sodium for Injection, USP 500 mg Multiple Dose Vial, Rx Only, Manufactured by: OneSource Specialty, Pharma Limited, Bengaluru - 561 203, India, Manufactured for: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, NDC 23155-893-31

Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.

If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.

2. Agency hazard and consumer action

FDA reports: Failed Impurities/Degradation Specifications

No consumer remedy instructions are supplied in this record. Check the official notice and listed company contact for the agency’s current instructions.

Class II: may cause temporary or medically reversible health consequences.

Affected product: Methohexital Sodium for Injection

3. Open the official notice or contact

Official recall ID
D-0662-2026
Brand
ONESOURCE SPECIALTY PHARMA
Classification
Class II
Units affected
4284 vials
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Affected products

Companies & origin

Recalling firm location
Bengaluru, N/A, India
Firm address
Plot No.: 2-D1, Obadenahalli Industrial Area, Doddaballapura, 3rd Phase; Kasa, Doddaballapura Taluk, N/A

Identifying details (verbatim from the notice)

Product codes / lots
Lot #: 7000612A, Exp. Date 1/2028
Distribution
Nationwide within the United States
Firm notified the public via
Letter
FDA event ID
99220
Recall initiated
June 7, 2026
FDA classified
July 7, 2026
FDA report date
July 15, 2026
Verify with the official sources:

Found something wrong or missing? Report a data error.

Source: U.S. Food & Drug Administration. Agency excerpts come from the public data feed and may omit tables or later changes; the linked government source is authoritative. Source last checked September 7, 2026 at 6:00 AM UTC. Record retrieved September 7, 2026 at 6:00 AM UTC.

Report a data error on this page